This is a modal window.
Anti-platelet Therapy and Anticoagulants in ACS Patients – Which? When? Why? – What if I Need to Stop? - Dr. Sukh Nijjer
Summary
Sukh Nijjer discusses the various antithrombotic treatments and combinations for ACS patients
- Different anti platelet options - aspirin, PSY12 antagonists, GpIIbIIIa antagonists
- ESC...
Summary
Sukh Nijjer discusses the various antithrombotic treatments and combinations for ACS patients
- Different anti platelet options - aspirin, PSY12 antagonists, GpIIbIIIa antagonists
- ESC guidelines
- Timing of anti platelet therapy - give at the time of making ACS diagnosis
- Pharmacokinetic profiles of the various drugs
- Duration of dual anti platelet therapy
- Stopping DAPT for bleeding or intercurrent surgery
- Bridging strategies
- Anticoagulant therapy - heparin, LMWH, bivalirudin, NOACs
- Co-existing AF and how to treat patients with AF and ACS/PCI
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Sukh Nijjer
Speaker
Dr Sukhjinder Nijjer is a Consultant Cardiologist and Honorary Senior Clinical Lecturer at... Dr Sukhjinder Nijjer is a Consultant Cardiologist and Honorary Senior Clinical Lecturer at Imperial College London. He is the President of Cardiology at the Royal Society of Medicine and is the Communication Lead for the British Cardiovascular Intervention Society. He works at the Hammersmith Hospital as an Interventional Cardiologist and is an expert in Coronary Physiology. His PhD research focused on the development of instantaneous wave-free ratio (iFR) pullback and co-registration. He has published over 100 original academic papers and has involved in the DEFINE-FLAIR, SYNTAX-II and ORBITA-1 and ORBITA-2 research studies.
